Jan David Hohmann - Search Results

Year	Number of Results
2011	3
2012	1
2013	1
2014	1
2015	1
2016	1
2017	1
2018	3
2019	1
2021	1
2024	0

1

Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.

Wang X, Searle AK, Hohmann JD, Liu AL, Abraham MK, Palasubramaniam J, Lim B, Yao Y, Wallert M, Yu E, Chen YC, Peter K. Wang X, et al. Among authors: hohmann jd. Mol Ther. 2018 Apr 4;26(4):1056-1065. doi: 10.1016/j.ymthe.2018.02.010. Epub 2018 Feb 16. Mol Ther. 2018. PMID: 29525742 Free PMC article.

2

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Wolf D, Anto-Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann JD, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc DM, Hilgendorf I, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von Zur Muhlen C, Reinöhl J, Gerhardt T, Plow EF, Yakubenko V, Libby P, Bode C, Ley K, Peter K, Zirlik A. Wolf D, et al. Among authors: hohmann jd. Nat Commun. 2018 Feb 6;9(1):525. doi: 10.1038/s41467-018-02896-8. Nat Commun. 2018. PMID: 29410422 Free PMC article.

3

A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.

Ziegler M, Hohmann JD, Searle AK, Abraham MK, Nandurkar HH, Wang X, Peter K. Ziegler M, et al. Among authors: hohmann jd. Eur Heart J. 2018 Jan 7;39(2):111-116. doi: 10.1093/eurheartj/ehx218. Eur Heart J. 2018. PMID: 28472483

4

Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.

Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K. Yap ML, et al. Among authors: hohmann jd. Theranostics. 2017 Jun 25;7(10):2565-2574. doi: 10.7150/thno.19900. eCollection 2017. Theranostics. 2017. PMID: 28819447 Free PMC article.

5

Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study.

Granja T, Körner A, Glück C, Hohmann JD, Wang X, Köhler D, Streißenberger A, Nandurkar HH, Mirakaj V, Rosenberger P, Peter K, Straub A. Granja T, et al. Among authors: hohmann jd. Crit Care Med. 2019 May;47(5):e420-e427. doi: 10.1097/CCM.0000000000003682. Crit Care Med. 2019. PMID: 30730441

6

A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices.

Abraham MK, Jost E, Hohmann JD, Searle AK, Bongcaron V, Song Y, Wendel HP, Peter K, Krajewski S, Wang X. Abraham MK, et al. Among authors: hohmann jd. Pharmaceutics. 2021 Sep 18;13(9):1504. doi: 10.3390/pharmaceutics13091504. Pharmaceutics. 2021. PMID: 34575580 Free PMC article.

7

An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia.

Topcic D, Kim W, Holien JK, Jia F, Armstrong PC, Hohmann JD, Straub A, Krippner G, Haller CA, Domeij H, Hagemeyer CE, Parker MW, Chaikof EL, Peter K. Topcic D, et al. Among authors: hohmann jd. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2015-23. doi: 10.1161/ATVBAHA.111.226241. Epub 2011 Jun 9. Arterioscler Thromb Vasc Biol. 2011. PMID: 21659646

8

Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.

Wang X, Gkanatsas Y, Palasubramaniam J, Hohmann JD, Chen YC, Lim B, Hagemeyer CE, Peter K. Wang X, et al. Among authors: hohmann jd. Theranostics. 2016 Mar 20;6(5):726-38. doi: 10.7150/thno.14514. eCollection 2016. Theranostics. 2016. PMID: 27022419 Free PMC article.

9

In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.

Abraham MK, Nolte A, Reus R, Behring A, Zengerle D, Avci-Adali M, Hohmann JD, Peter K, Schlensak C, Wendel HP, Krajewski S. Abraham MK, et al. Among authors: hohmann jd. PLoS One. 2015 Sep 18;10(9):e0138375. doi: 10.1371/journal.pone.0138375. eCollection 2015. PLoS One. 2015. PMID: 26381750 Free PMC article.

10

Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.

Wang X, Palasubramaniam J, Gkanatsas Y, Hohmann JD, Westein E, Kanojia R, Alt K, Huang D, Jia F, Ahrens I, Medcalf RL, Peter K, Hagemeyer CE. Wang X, et al. Among authors: hohmann jd. Circ Res. 2014 Mar 28;114(7):1083-93. doi: 10.1161/CIRCRESAHA.114.302514. Epub 2014 Feb 9. Circ Res. 2014. PMID: 24508759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year